PHC GROUPPHC Holdings Corporation

  • About Us
  • Group Companies
  • Products & Services
  • Sustainability
  • Investor Relations
  • Newsroom

About Us

Corporate Overview History Mission Vision Values Value Creation Plan Leadership

Group Companies

Ascensia LSI Medience Wemex Epredia PHCbi

Products & Services

Cancer Pathology Biologic & Cell Preservation Diagnostic Testing Patient Record & Billing Software Diabetes Management Medical Device & Drug Delivery

Sustainability

Sustainability
  • CEO Message
  • Materiality
  • Corporate Integrity image
    Corporate Integrity
  • People Insights image
    People Insights
  • Environmental Sustainability image
    Environmental Sustainability
  • Social Responsibility image
    Social Responsibility

Investor Relations

INVESTOR RELATIONS

MANAGEMENT

  • Corporate Governance
  • IR Basic Policy

IR LIBRARY

  • Financial Results
  • Presentation Materials
  • IR Materials
  • Mid-term Plan
  • Our Group Introduction

STOCK INFORMATION

  • Stock Overview
  • General Meeting of Shareholders
  • Stock Quotations
IR News Financial Highlights IR Calendar Contact IR Disclaimer

Newsroom

NEWSROOM

NEWS

  • PHC Holdings Corporation
  • PHC Group Companies
CareersContact
JP

Other PHC Group Websites

  • Ascensia Diabetes Care Holdings AG
  • PHC Corporation
  • LSI Medience Corporation
  • Wemex Corporation
  • Epredia Holdings Ltd.
  • PT PHC Indonesia
  • PHC Corporation of North America
  • PHC Europe B.V.
  • SciMed (ASIA) Pte Ltd
  • Amelieff Corporation

Other PHC Group Websites

  • Ascensia Diabetes Care Holdings AG
  • PHC Corporation
  • LSI Medience Corporation
  • Wemex Corporation
  • Epredia Holdings Ltd.
  • PT PHC Indonesia
  • PHC Corporation of North America
  • PHC Europe B.V.
  • SciMed (ASIA) Pte Ltd
  • Amelieff Corporation
CareersContactJP
Newsroom > 2022 > Announcement of Changes in Corporate Officers at PHC Holdings Corporation Effective June 13 and July 1, 2022

News


2022

NewsJune 13

Announcement of Changes in Corporate Officers at PHC Holdings Corporation Effective June 13 and July 1, 2022

Please be advised that the following changes will take place at PHC Holdings Corporation (headquarters: Minato-ku, Tokyo) effective June 13 and July 1, 2022.

(1) Objectives and Measures of this Change

PHC Holdings Corporation will centralize its management structure to reduce direct reporting lines to the President and CEO, for the purpose of improving the agility of our business. Under this new structure, the management team will continue to carry out the internal transformation necessary for our further evolution as a global healthcare company.

Regarding the new management structure, Shoji Miyazaki, President and CEO, stated, “The business environment surrounding PHC Group is changing rapidly and significantly. Short-term challenges include a slowdown of demand related to COVID-19 and the rise of costs related to logistics and raw materials. Mid- and long-term challenges include leveraging growth opportunities in the paradigm shift emerging in the healthcare industry, responding to the rise of new technologies and competitors, and ultimately enhancing the value of the business. As we are currently in simultaneous phases of turnaround and growth, I believe that forming this intense executive team will help this company navigate challenges by speeding up our decisions and actions. Our Vision, Mission, and Values, which guide our actions as a leading global healthcare company, remain unchanged.

(2) Changes in Corporate Officers Effective June 13, 2022

Promotion & Changes in Area of Responsibilities

Name Until June 12, 2022 From June 13, 2022
Ryuichi Hirashima Corporate Officer,
Chief Transformation Officer (CTO)・EVP
Senior Executive Corporate Officer,
Chief Administrative Officer (CAO)
Chief Human Resources Officer (CHRO)
Chief Transformation Officer (CTO)

General Affairs, Human Resources, Legal & Compliance, Intellectual Property, Transformation
Frederick Reidenbach Corporate Officer,
Chief Financial Officer (CFO)
Executive Corporate Officer,
Chief Financial Officer (CFO)

Corporate Accounting, Corporate Finance, Information Technology
Kaiju Yamaguchi Corporate Officer,
SVP, Corporate Development & Investor Relations
Executive Corporate Officer,
Chief Strategy Officer (CSO)

Corporate Strategy, Business Development, Investor Relations, Corporate Communications, Medical Policy & Public Affairs

Resignation

Name Position/Title
Jon Ebina Corporate Officer,
Chief Human Resources Officer (CHRO)

(3) Changes in Corporate Officers Effective July 1, 2022

New Appointment

Name Position/Title
Koichiro Sato Senior Executive Vice President,
Chief Operating Officer (COO)

Business Domains (Diabetes Management, Healthcare Solutions, Life Sciences/Diagnostics), Technology, Monozukuri, Procurement

(4) Corporate Officers at PHC Holdings Corporation on July 1, 2022

Position/Title Name Area of Responsibilities
Chief Executive Officer (CEO) Shoji Miyazaki Group Management, Internal Audit
Chief Operating Officer (COO) Koichiro Sato Business Domain (Diabetes Management, Healthcare Solutions, Life Sciences/Diagnostics), Technology, Manufacturing, Procurement
Senior Executive Corporate Officer
Chief Administrative Officer (CAO)
Chief Human Resources Officer (CHRO)
Chief Transformation Officer (CTO)
Ryuichi Hirashima General Affairs, Human Resources, Legal & Compliance, Intellectual Property, Transformation
Executive Corporate Officer
Chief Financial Officer (CFO)
Frederick Reidenbach Corporate Accounting, Corporate Finance, Information Technology
Executive Corporate Officer
Chief Strategy Officer (CSO)
Kaiju Yamaguchi Corporate Strategic, Business Development, Investor Relations, Corporate Communications, Medical Policy & Public Affairs
Corporate Officer Robert Schumm Head of Diabetes Management Domain
President,
Ascensia Diabetes Care Holdings AG
Corporate Officer Kyoji Morimoto Technology/Manufacturing
President,
PHC Corporation
Corporate Officer Nobuaki Nakamura Co-head of Life Sciences/Diagnostics Domain
Director, Member of Board
Biomedical Division, PHC Corporation
Corporate Officer Takayuki Otsuka Co-head of Healthcare Solutions Domain
Director, Member of Board
Medical Information Systems Division,
PHC Corporation
Corporate Officer Haruo Watanabe Co-head of Healthcare Solutions Domain
President and Chief Executive Officer,
LSI Medience Corporation
Corporate Officer John Sweeney Co-head of Life Sciences/Diagnostics Domain
President, Epredia

Media contact

Corporate Communications Group
PHC Holdings Corporation
+81-3-6778-5311
E-mail: phc-pr@gg.phchd.com

  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
Terms of UsePrivacy PolicyFacebookLinkedIn © PHC Holdings Corporation All rights reserved.